KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sabra Health Care REIT (SBRA) EBITDA Margin (2016 - 2026)

Sabra Health Care REIT has reported EBITDA Margin over the past 11 years, most recently at 58.13% for Q1 2026.

  • For Q1 2026, EBITDA Margin fell 2916.0% year-over-year to 58.13%; the TTM value through Mar 2026 reached 53.27%, up 153980.0%, while the annual FY2025 figure was 34.33%, 5121.0% down from the prior year.
  • EBITDA Margin for Q1 2026 was 58.13% at Sabra Health Care REIT, up from 25.93% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 162.66% in Q1 2022 and troughed at 31.85% in Q4 2024.
  • A 5-year average of 54.36% and a median of 58.13% in 2026 define the central range for EBITDA Margin.
  • Biggest five-year swings in EBITDA Margin: surged 12095bps in 2022 and later plummeted -14991bps in 2023.
  • Year by year, EBITDA Margin stood at 11.49% in 2022, then surged by 759bps to 75.71% in 2023, then plummeted by -142bps to 31.85% in 2024, then soared by 181bps to 25.93% in 2025, then skyrocketed by 124bps to 58.13% in 2026.
  • Business Quant data shows EBITDA Margin for SBRA at 58.13% in Q1 2026, 25.93% in Q4 2025, and 55.02% in Q3 2025.